Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Nitrous oxide induced myeloneuropathy: a case report.
Multiple sclerosis and pregnancy: maternal considerations.
Teriflunomide (AUBAGIO). Multiple sclerosis: just a metabolite of leflunomide.
Merck KGaA Reaches Mutual Agreement with Ono Pharmaceutical to Terminate the License Agreement on Ceralifimod (ONO-4641)
Cerebrospinal fluid α-synuclein levels are elevated in multiple sclerosis and neuromyelitis optica patients during replase.
[Oral disease modifying therapy of multiple sclerosis: the current view.]
Structural connectomics in brain diseases.
Sustained-Release Fampridine (4-Aminopyridine) in Multiple Sclerosis: Efficacy and Impact on Motor Function.
Comparing Two Deep Brain Stimulation Leads to One in Refractory Tremor.
Brain Region-specific Alterations in the Gene Expression of Cytokines, Immune Cell Markers and Cholinergic System Components During Peripheral Endotoxin-induced Inflammation.
A culture system to study oligodendrocyte myelination processes using engineered nanofibers.
FDA Accepts Biologics License Application For ZINBRYTA (Daclizumab High-Yield Process) For Treatment of MS
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial.
Change of fate commitment in adult neural progenitor cells subjected to chronic inflammation.
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation.
Extensive molluscum contagiosum virus infection in a young adult receiving fingolimod.
Effect of Multiple Infusions of AIN457 on Disease Activity in Relapsing-remitting Multiple Sclerosis
Treatment of resistant rheumatoid arthritis with minocycline: an open study.
Pathogenic features of CD4(+)CD28(-) T cells in immune disorders.
Accidental natalizumab administration in pregnancy in multiple sclerosis.
Dalfampridine improves walking speed, walking endurance, and community participation in veterans with multiple sclerosis: a longitudinal cohort study.
Atorvastatin added to interferon beta for relapsing multiple sclerosis: a randomized controlled trial.
Minocycline chelates Ca2+, binds to membranes, and depolarizes mitochondria by formation of Ca2+-dependent ion channels.
Overview of the biology of type I interferons.
Top 10 Research Questions Related to Physical Activity and Multiple Sclerosis.
Pages
« first
‹ previous
…
179
180
181
182
183
184
185
186
187
…
next ›
last »